HIGHLIGHTS
- What: We conclude that SID is prevalent in RA and PsA patients on immunosuppressive medications.
- Who: Secondary Immunodeficiency and colleagues from the Rheumatology, Rochester Regional Health, Rochester, USA Rheumatology, University of Rochester Medical have published the research: Review began 07/09/2024 Review ended 08/02/2024 Published 08/07/2024 © Copyright, in the Journal: (JOURNAL) of August/07,/2024
- Future: Future large randomized controlled studies are needed to assess each particular class of medication for its impact on developing SID.
SUMMARY
Previously, Holmes et_al described that RA patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.